Olfactory bulb glomeruli are formed by a network of 3 major types of neurons collectively called juxtaglomerular (JG) cells, which include external tufted (ET), periglomerular (PG) and short axon (SA) cells. There is solid evidence that GABA released from olfactory bulb PG neurons presynaptically inhibits glutamate release from olfactory nerve terminals via activation of GABA B receptors (GABA B -Rs). However, it is still unclear whether ET cells have GABA B -Rs.
INTRODUCTION
GABA B -Rs are broadly expressed in the nervous system and the GABA B -R agonist, baclofen, is used clinically to treat a wide variety of neurological and psychiatric disorders (for review, see Bettler et al. 2004; Bowery 2006) . In the rat main olfactory bulb, the glomeruli have the highest concentration of GABA B -Rs as determined by radioligand binding (Bowery et al. 1987; Chu et al. 1990 ) and by immunohistochemical localization of GABA B -R subunits (Bonino et al. 1999; Margeta-Mitrovic et al. 1999) . There is now strong evidence for GABA B -R-mediated presynaptic inhibition of glutamate release from olfactory nerve terminals (AroniadouAnderjaska et al. 2000; Keller et al. 1998; Murphy et al. 2005; Nickell et al. 1994; PalouzierPaulignan et al. 2002; Wachowiak and Cohen 1999; Wachowiak et al. 2005; Vucinic et al. 2006 ). However, it is unknown whether GABA B -Rs are located postsynaptically on JG cells and whether they can modulate the bursting pattern of ET cells.
GABA B -Rs are heterodimers consisting of two distinct subunits: GABA B1 and GABA B2 (for review, see Bettler et al. 2004; Emson 2007) . There have been few studies suggesting the presence of GABA B -R subunits on unidentified JG neurons. Immunolabeling for GABA B2 -Rs was found at symmetric dendrodendritic synapses and was associated with perisynaptic sites and the cytoplasmic face of the postsynaptic membrane, suggesting that postsynaptic GABA B -Rs may be expressed at junctions between PG interneurons and projection neurons (Kratskin et al. 2006) . Bonino et al. (1999) have shown the presence of postsynaptic GABA B -Rs on JG neurons using an antibody for both splice variants of the receptors (GABA B1a and GABA B1b ). It is unknown whether the GABA B1 and GABA B2 subunits are colocalized at glomerular synapses to form functional GABA B -Rs.
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In the hippocampus, GABA B -R activation has been reported to have an anticonvulsant-like effect by reducing the frequency of epileptiform burst firing (Ault et al. 1986; Swartzwelder et al. 1986 ). Usually metabotropic receptors are activated during bursts of synaptic input, during which a relatively high concentration of neurotransmitter is released in the synaptic cleft. In the olfactory bulb, ET cells exhibit rhythmic, intrinsically-generated spike bursts at theta frequencies, as it has been reported both in vivo (Getchell and Shepherd 1975; Wellis and Scott 1990) and in vitro (Antal et al. 2006; Hayar et al. 2004b) . They receive monosynaptic olfactory nerve input and provide intraglomerular excitatory monosynaptic input to PG and SA cells (Hayar et al. 2004a) . PG cells release GABA in a synchronized bursting fashion onto ET cells to induce feedback inhibition (Hayar et al. 2005) . One consequence of this GABA release might be to activate postsynaptic GABA B -Rs on ET cells and modulate their spontaneous bursting.
The effects of baclofen on the mode of bursting and on the membrane currents of ET cells might lead to modulation of dendrodendritic synaptic transmission between ET and PG cells. In particular, GABA B -Rs may modulate calcium channels which were shown recently to be located mostly on the distal dendrites of ET cells (Zhou et al. 2006) . Activation of presynaptic GABA BRs reduces neurotransmitter release at many central synapses (Misgeld et al. 1995; Chen and Pan 2006) . For instance, baclofen decreases GABA and glutamate release in hypothalamic paraventricular neurons (Cui et al. 2000; Wang et al. 2003) . However, in CA3 neurons of the hippocampus, baclofen decreases the frequency of miniature EPSCs, but not the frequency of miniature IPSCs (Scanziani et al. 1992) . These studies suggest that the synaptic GABA and glutamate release may be differentially regulated by GABA B -Rs in different brain regions. JG cells communicate mainly by dendrodendritic synapses (Pinching and Powell 1971a,b) .
Page 4 of 41 8 software. Data were then imported into Origin 7.0 (Microcal Software Inc., Northampton, MA) for further analysis using algorithms written in LabTalk. We evaluated the pattern of bursting of spikes throughout the experiments by measuring the following parameters: overall firing frequency, inter-burst frequency (defined as the number of bursts/sec), number of spikes/burst, intra-burst frequency (defined as the frequency of spikes within a burst), and burst duration (defined as the time interval between the first and the last spike in a burst). The intra-burst interspike interval slope (ms/interval) was calculated using the linear regression fit of inter-spike interval within the burst vs. the interval number. The slope was determined by the linear
, where n is the index number, X(n) is the interval number, Y(n) is the interval duration, Xm and Ym are mean values of the interval number and interval duration, respectively (Karpuk and Vorobyov 2003) . A burst of spikes was defined as a series of 3 or more consecutive spikes that had inter-spike time intervals of < 75 ms (i.e. an inter-spike time interval of > 75 ms was considered to signal the beginning of another burst). Auto-correlograms (Fig. 2) were normalized by dividing the counts in each bin by a coefficient (N), which is the number of events expected by chance during one bin: N = F1 x F2 x P x B; where F1 is the mean intra-burst frequency (Hz), F2 is the mean firing frequency (Hz), P is the sampling period (sec) used for analysis, B is the duration (sec) of one bin. Therefore, the coefficient of autocorrelation (C) at different time lag indicates the probability of occurrence of spikes in one bin compared to chance (i.e. when we assume random occurrence of spikes). Data, expressed as mean ± SEM, were statistically analyzed using 2-tailed paired t-test (Microsoft Excel 2003) unless otherwise stated.
Drugs
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RESULTS
Baclofen modulates spontaneous bursting of ET cells
We first investigated the effects of baclofen on ET cells using the loose-patch technique.
The advantage of this recording configuration is that the activity of ET cells is stable and does not undergo rundown as in whole-cell recordings due to intracellular dialysis (Hayar et al. 2004b ). To assess the postsynaptic effect of baclofen, we recorded ET cells in the presence of blockers of fast synaptic transmission, which included the non-NMDA receptor antagonist CNQX (10 LM), the NMDA receptor antagonist APV (50 LM), and the GABA A receptor antagonist gabazine (10 LM), which are referred to here as fast synaptic blockers. In these conditions, any effect observed would be most likely attributable to direct activation of GABA BRs located on ET cells since the major synaptic inputs to ET cells have been blocked (Hayar et al. 2004a (Hayar et al. ,b, 2005 Hayar and Ennis 2007) . ET cells can be readily identified in extracellular recordings because they exhibit spontaneous bursting that persists in the presence of synaptic blockers (Hayar et al. 2004a (Hayar et al. , b, 2005 Hayar and Ennis 2007) . Other cells which stopped bursting during drug application were excluded from the analysis. The bursting properties of the cells during application of the fast synaptic blockers were taken as control.
In a small percentage of ET cells (3 of 13 cells), baclofen (10 LM) completely inhibited the firing activity of ET cells. However, in most cases (10 of 13 cells), the effects of baclofen could not be explained simply by inhibition of firing activity. In order to analyze in details the effects of baclofen, we examined the pattern of bursting activity throughout the experiment by measuring the following parameters: firing frequency, inter-burst frequency, intra-burst frequency, number of spikes/burst, burst duration and intra-burst spike slope (see Methods for definitions). A moving average of each parameter was computed in order to dampen fast variations. Typical responses of baclofen on the bursting properties of an ET cell recorded extracellularly are shown in Figure 1 and a statistical analysis on a group of 10 cells is shown in Table 1 . Although not all cells were affected to the same degree by baclofen, on average, all bursting parameters showed statistically significant changes during baclofen application. All baclofen-induced effects almost completely reversed after addition of the GABA B -R blocker,
CGP55845 (10 LM).
Baclofen exerted a prominent effect on the spike, inter-burst and intra-burst frequencies. It reduced the spike frequency from 9.7 ± 1.7 Hz to 6.9 ± 1.6 Hz (P < 0.01) and the inter-burst frequency from 2.5 ± 0.5 bursts/s to 1.8 ± 0.5 bursts/s (P < 0.001). In contrast, baclofen significantly increased the number of spikes per burst from 4.6 ± 0.4 spikes/bursts to 5.7 ± 0.5 spikes/bursts (P < 0.01, Fig. 1 ) and the burst duration from 42 ± 6 ms to 47 ± 6 ms (P < 0.05).
The timing parameters of the bursts were further analyzed by constructing the auto-correlograms of intra-burst intervals ( Fig. 2A,B ). There was a progressive increase in inter-spike interval within individual bursts. We quantified this property by calculating the intra-burst inter-spike interval slope using linear regression method (Fig. 2C) . In control conditions, this slope was on average 5.6 ms/interval, indicating that every consecutive spike within a burst occurred with an interval that is about 5.6 ms longer than the previous inter-spike interval. The intra-burst interspike interval slope was decreased by baclofen from 5.6 ± 1.2 ms/interval to 3.4 ± 0.84 ms/interval (P < 0.01) suggesting that there is a tendency of relatively less spike firing adaptation within the burst during activation of the GABA B -Rs. The average intra-burst spike frequency, which takes into account all inter-spike intervals within a burst, increased from 88 ± 9.5 Hz to burst frequencies of ET cells were reduced by baclofen, the bursts become stronger since there were more spikes in a burst and these spikes occurred at shorter intervals.
Despite the effectiveness of CGP55845 in reversing the effects of baclofen on the bursting pattern (Table 1) , we did not observe any significant effect of CGP55845 when applied alone.
For instance, the spike firing rate in control conditions was not significantly changed by application of CGP55845 (control: 8.9 ± 2.3 Hz, CGP55845: 9.8 ± 2.9 Hz, n = 7, P = 0.24).
Similarly, the inter-burst frequency was not significantly changed by application of CGP55845 (control: 2.5 ± 0.7 bursts/s, CGP55845: 2.6 ± 0.76 bursts/s, n = 5, P = 0.24). These results suggest that the bursting pattern of ET cells can be modulated by activation of GABA B -Rs, but these receptors do not seem to be tonically active under our testing conditions. It is possible that GABA B -Rs might be activated during olfactory nerve stimulation which triggers massive GABA release from PG cells leading to a barrage of IPSCs in ET cells (Hayar et al. 2005) . However, endogenous GABA, released by olfactory nerve stimulation, also activates presynaptic GABA BRs located on the olfactory nerve terminals (Aroniadou-Anderjaska et al. 2000) . Therefore, it is not technically possible to differentiate between activation of the pre-versus postsynaptic GABA B -Rs because of the lack of selective antagonists.
Baclofen exerts direct effects on the membrane properties of ET cells
The previous results indicate that activation of GABA B -Rs on ET cells reduces the overall activity of these cells by decreasing their firing and inter-burst frequencies but it paradoxically strengthens the bursts by increasing the number of spikes/burst and the intra-burst frequency. The previous results do not rule out the possibility that baclofen may exert its effects, at least in part, indirectly by inhibiting action potential-dependant release of neurotransmitters that act slowly via metabotropic receptors (e.g. glutamatergic, serotonergic and dopaminergic receptors). To investigate whether baclofen exerts direct effects on ET cells, we further blocked action potentials by application of the sodium channel blocker, TTX, in addition to blockade of fast glutamatergic and GABAergic transmission. Baclofen was tested in voltage clamp mode at HP of -60 mV during application of CNQX+APV+gabazine+TTX. At 10 LM, baclofen produced no significant effect on the holding current whereas at 50 LM, it induced an outward current of 16 ± 3.3 pA (n = 7, P < 0.01, Fig. 3B ). Such outward current corresponded to a hyperpolarization of the resting membrane potential by 8.0 ± 1.9 mV (from -55.1 ± 3.5 mV to -63.1 ± 2.9 mV; calculated as the voltage level at which no current was injected in the cell, n = 7). We also tested baclofen on the membrane input resistance which was calculated as the slope of linear regression fit of the voltage-current relationship. In the presence of CNQX+APV+gabazine+TTX (control), baclofen significantly decreased the input resistance, and this effect was partially reversed by additional application of CGP55845 (control: 625 ± 97 MN, baclofen: 536 ± 87 MN, CGP55845: 611 ± 100 MN; n = 7; P < 0.05, Fig. 3C ). The current activated by baclofen tended to reverse at holding potentials ranging from -85 to -95 mV, close to the equilibrium potential of potassium ions suggesting the involvement of potassium channels in the GABA B -R-mediated response. Taken together these results suggest the presence on ET cells of functional postsynaptic GABA B -Rs that can be directly activated by baclofen. Although baclofen produced relatively small changes on the membrane potential and current of ET cells, these changes seem to lead to prominent modulation of the bursting pattern of ET cells. The relatively large effects of baclofen (10 LM) on the bursting compared to its insignificant effect on the membrane current could be due to additional GABA B -R-mediated modulation of voltage-dependent channels that are not active at HP of -60 mV. It is also possible that baclofen responses were reduced in wholecell recordings due to a decrease in the affinity of GABA B -Rs because of washout of intracellular messengers involved in the transduction mechanism of these receptors.
Baclofen inhibits spontaneous and evoked EPSCs in JG cells
The effects (Fig. 4) . Baclofen blocked almost completely the spontaneous bursts of EPSCs and reduced the frequency of all EPSCs in PG and SA cells from 11.7 ± 4.1 to 5.2 ± 3.2 Hz (n = 6, P < 0.05). The average spontaneous EPSC amplitude was also reduced by baclofen from 34 ± 4 pA to 27 ± 3 pA (n = 6, P < 0.05). These data suggest that baclofen reduced dendrodendritic spontaneous glutamatergic release onto JG interneurons.
We next stimulated the olfactory nerve layer to evoke disynaptic bursts of EPSCs in PG or SA cells. The evoked bursts of EPSCs resulted from direct activation of ET cells by olfactory nerve axons and subsequent release of glutamate from ET cells via direct synaptic coupling between ET and PG cells (Hayar et al. 2004a ). The olfactory nerve-evoked bursts of EPSCs were either eliminated (i.e. failure) by baclofen or reduced in peak amplitude (calculated after averaging the compound evoked EPSCs in10 trials in each condition), which on average decreased from 125 ± 26 pA to 26 ± 6.4 pA (n = 6, P < 0.01). Baclofen increased the average latency from 6.7 ± 2.1 ms to 10.3 ± 1.3 ms (n = 6, P < 0.05) and the average time-to-peak of the evoked EPSC bursts from 22.7 ± 8.4 ms to 70.1 ± 17.8 ms (n = 6, P < 0.01; calculated between the stimulating pulse and the maximal amplitude of the average evoked response) (Fig. 4) . These results suggest that the olfactory nerve-evoked bursts of EPSCs were not monosynaptically driven and that the increase in delay was probably caused by the longer time needed for the monosynaptically-evoked EPSPs in ET cells to reach threshold for triggering spike bursts (Hayar et al. 2004a ). The effects of baclofen were reversed after addition of the GABA B -R blocker, CGP55845, to the bath. Taken together, these results indicate that activation of GABA B -Rs has considerable inhibitory effect on the polysynaptic pathway involving glutamatergic transmission from olfactory nerve axons to ET cells and then to PG cells. However, at this stage, it is unknown whether these effects are due to direct inhibition of ET cell bursting by baclofen (previous results) or due to direct inhibition of glutamatergic release from ET cell dendrites. To resolve this issue, we investigated the effects of baclofen on action potential-independent EPSCs in PG or SA cells.
The spontaneous EPSCs recorded in PG and SA cells correspond to the sum of two types of synaptic activity. One is resistant to TTX and corresponds to the action potential-independent spontaneous release of glutamate at synapses (miniature EPSCs, mEPSCs). The other type of activity is TTX-sensitive because it is evoked by action potential propagation in dendrites of The relatively low frequency of mEPSCs in PG and SA cells precluded the possibility of further examining an additional inhibitory effect of baclofen. Additionally, we observed that application of 50 LM baclofen induced an outward current of up to 20 pA in some PG cells during TTX application (not shown). Therefore, it is possible that in these conditions baclofen could activate potassium channels leading to a decrease in resistance, which might affect the detectability of mEPSCs. In order to circumvent these potential problems, we filled the patch pipette with a solution that contains the potassium and sodium channel blockers, cesium and QX-314, respectively. Moreover, we enhanced spontaneous glutamatergic release that is independent of spiking activity by applying, in addition to TTX and gabazine, the potassium channel blockers, TEA (10 mM) and barium (1 mM). The frequency of mEPSCs in this cocktail of blockers was considerably higher (11.3 ± 4.7 Hz, n = 6) than during application of TTX alone (P < 0.01, unpaired t-test). It should also be noted that mEPSC activity in the presence of this cocktail of blockers become highly irregular with frequent changes in mEPSC frequency and amplitude. Nevertheless, in these conditions, baclofen (50 LM) produced significant inhibitory effects on mEPSCs (Fig. 5) by reducing their frequency from 11.3 ± 4.7 Hz to 5.2 ± 2.0 Hz (n = 6, 4 PG cells and 2 SA cells, P < 0.05) without significantly changing the mEPSC amplitude (control: 12.3 ± 1.2 pA, baclofen: 10.9 ± 0.8 pA, n = 6, P = 0.173). The effect of baclofen on the mEPSC frequency was reversed after addition of the GABA B -R blocker, CGP55845 (20.6 ± 4.7 Hz, n = 5, P < 0.05). Despite the apparent increase of mEPSC frequency in CGP55845 compared to control before baclofen application, this increase did not reach statistical significance (P = 0.06). Additional application of cadmium (200 LM) significantly decreased the frequency of mEPSCs by 82% from 20.6 ± 4.7 to 3.6 ± 0.54 Hz (n = 5, P < 0.05). Although not all mEPSCs were suppressed by cadmium, these results suggest that the majority of the mEPSCs that were inhibited by baclofen were dependent on calcium influx into ET cell dendrites. We do not, however, exclude the possibility that baclofen might also reduce calcium-independent mEPSCs. The interactions of excitatory and inhibitory inputs on ET cell dendrites provide a rich source of computation possibilities. In a previous study, we showed that ET cell bursting is controlled and coordinated by fast excitatory and inhibitory synaptic inputs, which strengthen and weaken bursting, respectively, by modulating the number of spikes/burst (Hayar and Ennis 2007). Therefore, ET cell excitatory and inhibitory inputs may be encoded as a change in the pattern of spike bursting. In this study, we showed that activation of GABA B -Rs decreased the bursting frequency but it increased the burst duration and the number of spikes/burst. These effects were obtained in the presence of fast synaptic blockers and are therefore most likely due to postsynaptic modulation of membrane channels. The decrease in bursting frequency could be explained in part by hyperpolarization of the membrane potential, which was observed in whole- (Azouz et al. 1996) . It is possible that the burst is normally terminated by a calcium-dependent potassium conductance. In this case, an inhibition of calcium influx would inhibit the calcium-activated slow after-hyperpolarization that contributes to burst termination. This interpretation is supported by our finding that baclofen reduced spike firing adaptation in the burst, which was quantified by the inter-spike interval slope. In this study, we tested baclofen specifically on PG cells that have no direct connection to the olfactory nerve by selecting those cells that responded to olfactory nerve with a relatively long and variable latency burst of EPSCs (Hayar et al. 2004a) . We found that baclofen almost completely inhibited olfactory nerve-evoked EPSC bursts in PG cells. These evoked EPSC bursts are produced disynaptically via initial activation of ET cells, which generate burst of spikes and subsequently release glutamate from their dendrites onto PG cells. In this case, the observed strong inhibition of baclofen on the evoked bursts of EPSCs could occur at many levels: 1) presynaptic inhibition of olfactory axons that innervate directly the ET cells, 2) postsynaptic activation of GABA B -Rs on ET cells, and 3) inhibition of glutamate release from ET cell to PG cell dendrites.
To investigate specifically the last mechanism, we tested baclofen on mEPSCs in the presence of TTX to block action potential-dependent synaptic release and the potassium channel blockers TEA and barium to block inwardly rectifying potassium channels which might be activated by GABA B -Rs. In the presence of these sodium and potassium channel blockers, baclofen significantly reduced the mEPSCs in PG and SA cells. Because the majority of these mEPSCs (82%) were blocked by cadmium, these results provide indirect evidence that activation of GABA B -Rs may reduce calcium influx into the ET cell dendrites, which then release less glutamate onto PG and SA cells.
It is possible that activation of potassium channels by GABA B -Rs could be a sufficient mechanism to explain the inhibition of transmitter release from ET to PG and SA cells.
However, our experiments on mEPSCs were performed in the presence of the potassium channel blockers: cesium applied intracellularly in the pipette solution and TEA and barium applied extracellularly in the bath solution. Since sodium channels were also blocked by TTX in these experiments, we assume that in these conditions, voltage-dependent calcium channels were the only active channels. Therefore, by exclusion, our data suggest that the decrease of mEPSCs by baclofen may involve calcium channels assuming that the potassium channel blockers in particular, barium has blocked the inwardly rectifying potassium channels that were activated by GABA B -Rs (Gahwiler and Brown 1985; Inoue et al. 1985; Ogata 1990; Rossi et al. 2006 ).
Despite the overall inhibitory effect of baclofen on ET cell firing activity, its paradoxical increase of the number of spikes/bursts would lead to facilitation of transmitter release since additional spikes are expected to increase the probability of synaptic release due to an increase in calcium influx in the dendrites (Murphy et al. 2005; Zhou et al. 2006) . This indicates that an additional mechanism other than opening of potassium channels may be involved in the reduction of transmitter release by baclofen. We propose that the GABA B -R-mediated inhibition of dendrodendritic transmitter release may result from the synergistic effects of activation of potassium channels as well as the inhibition of calcium channels. However, direct evidence for inhibition of ET cell calcium currents by baclofen (unpublished data, Karpuk and Hayar 2007) would be required to fully support this hypothesis.
Our findings are in contrast with the absence of effect of baclofen on glutamate release from the lateral dendrites of mitral and tufted cells. In one study, the field potential recorded in the granule cell layer in response to lateral olfactory tract stimulation was not affected by baclofen (Aroniadou-Anderjaska et al. 2000) . In another study, baclofen exerted only a modest inhibitory role on mitral cell dendritic glutamate release but it strongly reduced GABA release This effect was reversed by the GABA B -R blocker, CGP55845. B. Auto-correlograms of interspike intervals within bursts constructed using spike occurrence in 2 minute sampling periods in different pharmacological conditions. The auto-correlograms were normalized to the bin width, the sampling period, the firing frequency, and the inter-burst frequency (see Methods). C.
Evaluation of the slopes of the inter-spike intervals as a function of the interval number within a burst. The slopes were calculated using linear regression fit in different pharmacological conditions. All data obtained in this figure were obtained from the same cell. Baclofen induced an outward current that was reversed by the GABA B -R receptor antagonist, CGP55845. C. Plot of the current-voltage relationship in the same ET cell as in (B) in different pharmacological conditions. Baclofen produced an outward current at membrane potentials above -90 mV and an inward current at membrane potentials below -90 mV, which is near the reversal potential of potassium channels. Inset shows current response to a 50 mV hyperpolarizing voltage step from -60 mV to -110 mV (duration 0.5 s) in different pharmacological conditions. During baclofen application, a larger current (dotted trace) was produced in response to the same voltage step indicating an increase in conductance (i.e. decrease in resistance) of the cell in response to GABA B -R activation. Spike frequency (Hz) 9.7 ± 1.7 6.9 ±1.6** 9.2 ± 1.5** increased the regularity of inter-spike intervals within the burst as shown by the decrease in the variability of the data points which show higher density around regularlyspaced peaks. Additional application of baclofen reduced the inter-spike intervals and introduced additional peaks due to the recruitment of more spikes. This effect was reversed by the GABAB-R blocker, CGP55845. B. Auto-correlograms of inter-spike intervals within bursts constructed using spike occurrence in 2 minute sampling periods in different pharmacological conditions. The auto-correlograms were normalized to the bin width, the sampling period, the firing frequency, and the inter-burst frequency (see Methods). C. Evaluation of the slopes of the inter-spike intervals as a function of the interval number within a burst. The slopes were calculated using linear regression fit in different pharmacological conditions. All data obtained in this figure were obtained from the same cell. Baclofen produced an outward current at membrane potentials above -90 mV and an inward current at membrane potentials below -90 mV, which is near the reversal potential of potassium channels. Inset shows current response to a 50 mV hyperpolarizing voltage step from -60 mV to -110 mV (duration 0.5 s) in different pharmacological conditions. During baclofen application, a larger current (dotted trace) was produced in response to the same voltage step indicating an increase in conductance (i.e. decrease in resistance) of the cell in response to GABAB-R activation. 
